BMS & Otsuka Expand Their Abilify Deal, Enter into New Oncology Co-Promotion
This article was originally published in The Pink Sheet Daily
Executive Summary
The new deal enables BMS to smooth out its earnings in the face of a looming patent cliff and gives Otsuka an entrée into oncology.